Clinical Trial Update: RESET System Pivotal Trial (Rev F) [NA]

View source ↗

Summary

Morphic Medical's RESET System pivotal trial (Rev F) is currently recruiting, evaluating the device for Type 2 diabetes mellitus and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• RESET System

Snippet

Sponsor: Morphic Medical Inc. | Conditions: Diabetes type2, Obesity | NA | Status: RECRUITING